OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 22.00
+1.00 (4.76%)
At close: Mar 27, 2026
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 8.29 billion as of March 27, 2026. Its market cap has increased by 12.98% in one year.
Market Cap
8.29B
Enterprise Value
6.10B
Revenue
784.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 8.29B, a decrease of -40.14%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.29B | 20.56% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 10.28B |
| K Pharma,Inc. | 9.59B |
| StemCell Institute | 8.40B |
| ADR120S | 7.93B |
| MEDINET | 7.73B |
| CellSource | 7.70B |
| Carna Biosciences | 7.69B |
| Chiome Bioscience | 7.29B |